Learn how international governments have committed themselves to improving access to quality health care!
International Drug Regulatory Mechanisms explores the environment, organization, structure, functioning, and finance of health systems and pharmaceutical markets in 19 countries. Local experts describe each country’s experiences with and lessons learned from the regulation of pharmaceutical products. This book will help government officials, pharmacy educators, and pharmaceutical industry leaders from around the globe identify and develop successful methods for controlling pharmaceutical drug prices and utilization.
In International Drug Regulatory Mechanisms, you will learn about the health care system of each country and each government’s measures to control drug costs. This text shows you what government interventions are feasible as well as effective, and the impact of these measures on consumers, government agencies, and the pharmaceutical companies and distributors. Drug policies, reimbursement concepts, and health insurance companies are all examined to give you a better working knowledge of the methodology and guidelines involving drug control in nations such as
Iceland
Canada
Israel
Malaysia
Argentina
Taiwan
Mexico
Italy
International Drug Regulatory Mechanisms is an extensive text that shows how pharmaceuticals are regulated throughout the world. This book examines how—despite similar goals—price controls, utilization controls, record keeping, and quality requirements differ greatly between countries. Using numerous graphs, tables, and figures, this one-of-a-kind resouce provides you with new insight into which strategies are superior and how to implement these strategies in your own country.
Author(s): Albert I. Wertheimer, Mickey C. Smith
Publisher: CRC Press
Year: 2022
Language: English
Pages: 381
City: Boca Raton
Cover
Half Title
Title
Copyright
Contents
Foreword
Interventions to Curb Rising Pharmaceutical Costs in Iceland
Canadian Public Policies and Practices Related to Drug Prices, Utilization and Expenditures
Drug Policy in the Czech Republic
Drug Policies and Pricing Mechanism: The Malaysian Perspective
Drug Pricing in South Africa–Policy and Praxis
Drug Price Control in India–An Overview
Pharmaceutical Benefit Scheme and Cost Containment in Taiwan’s National Health Insurance
RX Price Control Methods in Mexico
Financing Pharmaceutical Care in the Dutch Health System
Drug Pricing Policy in Hungary
Germany’s Attempts to Control Drug Prices and Expenditures: Success or Failure?
Regulating the Prices and Costs of Medicines in the United Kingdom
The Controls of Prices of Medicines in Israel
Pharmaceutical Services in Slovenia
Pricing and Reimbursement of Medicinal Products in Denmark
Drug Prices in Argentina
Drug Pricing and Reimbursement System in Turkey
Medication Expenditure and Utilization in Morocco
Pharmaceutical Expenditure: Aspects of Cost Containment in Italy
Organization of Health Care Systems and Financing of Pharmaceuticals in Norway, Including Cost Containments
Index